Best TWAS P=7.17e-68 · Best GWAS P=6.13e-59 conditioned to 0.00303
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Breast Mammary Tissue | AGAP7 | 0.50 | 0.21 | enet | 27 | 0.35 | 5.5e-19 | 0.49 | -5.3 | 9.4e-08 | -0.20 | 1.00 | 0.00 | FALSE |
2 | GTEx | Breast Mammary Tissue (Female) | RP11-592B15.4 | 0.14 | 0.06 | enet | 7 | 0.09 | 1.3e-03 | -2.50 | -7.4 | 1.8e-13 | -0.46 | 0.03 | 0.45 | FALSE |
3 | GTEx | Breast Mammary Tissue (Female) | PARG | 0.10 | -0.01 | enet | 21 | -0.01 | 9.5e-01 | 0.14 | 5.7 | 1.1e-08 | 0.42 | 0.02 | 0.13 | FALSE |
4 | GTEx | Colon Sigmoid | AGAP7 | 0.36 | 0.20 | enet | 13 | 0.26 | 6.6e-10 | -3.47 | -7.0 | 1.8e-12 | -0.24 | 0.88 | 0.08 | FALSE |
5 | GTEx | Esophagus Muscularis | AGAP7 | 0.26 | 0.14 | enet | 21 | 0.18 | 3.8e-11 | 0.49 | -5.8 | 6.7e-09 | -0.23 | 0.98 | 0.01 | FALSE |
6 | GTEx | Liver | AGAP7 | 0.37 | 0.01 | enet | 22 | 0.10 | 1.1e-03 | -3.47 | -5.9 | 3.0e-09 | -0.26 | 0.02 | 0.06 | FALSE |
7 | GTEx | Prostate | NCOA4 | 0.20 | 0.18 | lasso | 2 | 0.16 | 6.4e-05 | 17.20 | 17.4 | 7.2e-68 | 0.92 | 0.00 | 0.97 | TRUE |
8 | GTEx | Whole Blood | AGAP7 | 0.13 | 0.08 | lasso | 3 | 0.10 | 6.2e-10 | 14.43 | -12.3 | 1.5e-34 | -0.79 | 0.88 | 0.09 | FALSE |
9 | NTR | Blood | NCOA4 | 0.02 | 0.01 | enet | 6 | 0.01 | 2.6e-04 | 14.66 | -15.1 | 3.3e-51 | -0.87 | 0.02 | 0.97 | FALSE |
10 | YFS | Blood | AGAP6 | 0.13 | 0.10 | enet | 24 | 0.10 | 8.0e-32 | 14.43 | -13.0 | 9.7e-39 | -0.90 | 0.89 | 0.11 | TRUE |
11 | YFS | Blood | AGAP8 | 0.36 | 0.32 | bslmm | 200 | 0.34 | 1.1e-116 | 14.43 | -12.9 | 2.5e-38 | -0.87 | 1.00 | 0.00 | FALSE |
12 | YFS | Blood | NCOA4 | 0.15 | 0.15 | lasso | 5 | 0.18 | 9.5e-56 | 14.43 | -13.2 | 1.4e-39 | -0.90 | 1.00 | 0.00 | FALSE |
13 | The Cancer Genome Atlas | Prostate Adenocarcinoma | NCOA4 | 0.05 | 0.01 | enet | 2 | 0.02 | 1.1e-03 | 7.10 | 9.5 | 2.2e-21 | 0.36 | 0.00 | 0.51 | FALSE |